Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 304

1.

Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.

Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL.

Ann Intern Med. 2011 Oct 18;155(8):481-92. doi: 10.7326/0003-4819-155-8-201110180-00004. Erratum in: Ann Intern Med. 2014 May 6;160(9):658.

2.

Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.

O'Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus KL, Geller B, Wernli KJ, Miglioretti DL.

Cancer. 2013 Nov 15;119(22):3959-67. doi: 10.1002/cncr.28310.

3.

Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.

Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli KJ, Miglioretti DL, O'Meara ES; Breast Cancer Surveillance Consortium..

JAMA Intern Med. 2013 May 13;173(9):807-16. doi: 10.1001/jamainternmed.2013.307.

4.

Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?

Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K; Breast Cancer Surveillance Consortium..

J Natl Cancer Inst. 2013 Mar 6;105(5):334-41. doi: 10.1093/jnci/djs645.

5.

Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.

Dittus K, Geller B, Weaver DL, Kerlikowske K, Zhu W, Hubbard R, Braithwaite D, O'Meara ES, Miglioretti DL; Breast Cancer Surveillance Consortium..

J Gen Intern Med. 2013 Nov;28(11):1454-62. doi: 10.1007/s11606-013-2507-0.

6.

Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50.

Winch CJ, Sherman KA, Boyages J.

Breast Cancer Res Treat. 2015 Jan;149(1):211-21. doi: 10.1007/s10549-014-3226-x.

PMID:
25476499
7.

Benefits and Harms of Breast Cancer Screening: A Systematic Review.

Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, Davidson B, Mongtomery RC, Crowley MJ, McCrory DC, Kendrick A, Sanders GD.

JAMA. 2015 Oct 20;314(15):1615-34. doi: 10.1001/jama.2015.13183. Review. Erratum in: JAMA. 2016 Apr 5;315(13):1406.

8.

The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.

Roman M, Hubbard RA, Sebuodegard S, Miglioretti DL, Castells X, Hofvind S.

Cancer. 2013 Nov 15;119(22):3952-8. doi: 10.1002/cncr.28320.

9.

Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.

Miglioretti DL, Zhu W, Kerlikowske K, Sprague BL, Onega T, Buist DS, Henderson LM, Smith RA; Breast Cancer Surveillance Consortium..

JAMA Oncol. 2015 Nov;1(8):1069-77. doi: 10.1001/jamaoncol.2015.3084.

10.
11.

Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.

Nelson HD, O'Meara ES, Kerlikowske K, Balch S, Miglioretti D.

Ann Intern Med. 2016 Feb 16;164(4):226-35. doi: 10.7326/M15-0971.

12.

Biennial versus annual mammography and the risk of late-stage breast cancer.

White E, Miglioretti DL, Yankaskas BC, Geller BM, Rosenberg RD, Kerlikowske K, Saba L, Vacek PM, Carney PA, Buist DS, Oestreicher N, Barlow W, Ballard-Barbash R, Taplin SH.

J Natl Cancer Inst. 2004 Dec 15;96(24):1832-9.

PMID:
15601639
13.

[Tailored Breast Screening Trial (TBST)].

Paci E, Mantellini P, Giorgi Rossi P, Falini P, Puliti D; TBST Working Group..

Epidemiol Prev. 2013 Jul-Oct;37(4-5):317-27. Italian.

14.
15.

Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.

Duijm LE, Groenewoud JH, de Koning HJ, Coebergh JW, van Beek M, Hooijen MJ, van de Poll-Franse LV.

Eur J Cancer. 2009 Mar;45(5):774-81. doi: 10.1016/j.ejca.2008.10.020.

PMID:
19046632
16.

Re-attendance at biennial screening mammography following a repeated false positive recall.

Klompenhouwer EG, Duijm LE, Voogd AC, den Heeten GJ, Strobbe LJ, Louwman MW, Coebergh JW, Venderink D, Broeders MJ.

Breast Cancer Res Treat. 2014 Jun;145(2):429-37. doi: 10.1007/s10549-014-2959-x.

PMID:
24748569
17.

Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.

van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ.

Ann Intern Med. 2012 May 1;156(9):609-17. doi: 10.7326/0003-4819-156-9-201205010-00002.

18.

Performance of first mammography examination in women younger than 40 years.

Yankaskas BC, Haneuse S, Kapp JM, Kerlikowske K, Geller B, Buist DS; Breast Cancer Surveillance Consortium..

J Natl Cancer Inst. 2010 May 19;102(10):692-701. doi: 10.1093/jnci/djq090.

19.

Variability of interpretive accuracy among diagnostic mammography facilities.

Jackson SL, Taplin SH, Sickles EA, Abraham L, Barlow WE, Carney PA, Geller B, Berns EA, Cutter GR, Elmore JG.

J Natl Cancer Inst. 2009 Jun 3;101(11):814-27. doi: 10.1093/jnci/djp105.

20.

Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force [Internet].

Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan.

Supplemental Content

Support Center